{"id":"https://openalex.org/W4388014101","doi":"https://doi.org/10.1158/2326-6066.cir-23-0072","title":"T cell\u2013Dependent Bispecific Therapy Enhances Innate Immune Activation and Antibody-Mediated Killing","display_name":"T cell\u2013Dependent Bispecific Therapy Enhances Innate Immune Activation and Antibody-Mediated Killing","alternate_titles":[],"publication_year":2023,"publication_date":"2023-10-27","ids":{"openalex":"https://openalex.org/W4388014101","doi":"https://doi.org/10.1158/2326-6066.cir-23-0072","pmid":"https://pubmed.ncbi.nlm.nih.gov/37902604"},"language":"en","primary_location":{"id":"doi:10.1158/2326-6066.cir-23-0072","doi":"https://doi.org/10.1158/2326-6066.cir-23-0072","is_oa":false,"landing_page_url":"https://doi.org/10.1158/2326-6066.cir-23-0072","pdf_url":null,"source":{"id":"https://openalex.org/S2765010658","display_name":"Cancer Immunology Research","issn_l":"2326-6066","issn":["2326-6066","2326-6074"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Immunology Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4388014101"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071518816","display_name":"Rickvinder Besla","orcid":"https://orcid.org/0009-0007-8623-7488","observed_orcids":["https://orcid.org/0009-0007-8623-7488"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rickvinder Besla","raw_affiliation_strings":["1Genentech Research and Early Development, Genentech Inc., South San Francisco, California"],"raw_orcid":"https://orcid.org/0009-0007-8623-7488","affiliations":[{"raw_affiliation_string":"1Genentech Research and Early Development, Genentech Inc., South San Francisco, California","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090977353","display_name":"Elicia M. Penuel","orcid":"https://orcid.org/0000-0001-7285-1929","observed_orcids":["https://orcid.org/0000-0001-7285-1929"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elicia Penuel","raw_affiliation_strings":["1Genentech Research and Early Development, Genentech Inc., South San Francisco, California"],"raw_orcid":"https://orcid.org/0000-0001-7285-1929","affiliations":[{"raw_affiliation_string":"1Genentech Research and Early Development, Genentech Inc., South San Francisco, California","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067029517","display_name":"Geoff Del Rosario","orcid":"https://orcid.org/0009-0007-8179-4250","observed_orcids":["https://orcid.org/0009-0007-8179-4250"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Geoff Del Rosario","raw_affiliation_strings":["1Genentech Research and Early Development, Genentech Inc., South San Francisco, California"],"raw_orcid":"https://orcid.org/0009-0007-8179-4250","affiliations":[{"raw_affiliation_string":"1Genentech Research and Early Development, Genentech Inc., South San Francisco, California","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074986923","display_name":"Ely Cosino","orcid":"https://orcid.org/0009-0007-3164-1045","observed_orcids":["https://orcid.org/0009-0007-3164-1045"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ely Cosino","raw_affiliation_strings":["1Genentech Research and Early Development, Genentech Inc., South San Francisco, California"],"raw_orcid":"https://orcid.org/0009-0007-3164-1045","affiliations":[{"raw_affiliation_string":"1Genentech Research and Early Development, Genentech Inc., South San Francisco, California","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047140889","display_name":"Szymon Myrta","orcid":"https://orcid.org/0000-0003-1714-6105","observed_orcids":["https://orcid.org/0000-0003-1714-6105"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Szymon Myrta","raw_affiliation_strings":["2Roche Global IT Solution Centre, Warsaw, Poland"],"raw_orcid":"https://orcid.org/0000-0003-1714-6105","affiliations":[{"raw_affiliation_string":"2Roche Global IT Solution Centre, Warsaw, Poland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Mike Dillon","orcid":"https://orcid.org/0000-0003-3240-9882","observed_orcids":["https://orcid.org/0000-0003-3240-9882"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mike Dillon","raw_affiliation_strings":["1Genentech Research and Early Development, Genentech Inc., South San Francisco, California"],"raw_orcid":"https://orcid.org/0000-0003-3240-9882","affiliations":[{"raw_affiliation_string":"1Genentech Research and Early Development, Genentech Inc., South San Francisco, California","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089995503","display_name":"Greg A. Lazar","orcid":"https://orcid.org/0000-0003-2169-8703","observed_orcids":["https://orcid.org/0000-0003-2169-8703"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Greg A. Lazar","raw_affiliation_strings":["1Genentech Research and Early Development, Genentech Inc., South San Francisco, California"],"raw_orcid":"https://orcid.org/0000-0003-2169-8703","affiliations":[{"raw_affiliation_string":"1Genentech Research and Early Development, Genentech Inc., South San Francisco, California","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003498756","display_name":"Dorothee Nickles","orcid":"https://orcid.org/0009-0002-5295-1062","observed_orcids":["https://orcid.org/0009-0002-5295-1062"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dorothee Nickles","raw_affiliation_strings":["1Genentech Research and Early Development, Genentech Inc., South San Francisco, California"],"raw_orcid":"https://orcid.org/0009-0002-5295-1062","affiliations":[{"raw_affiliation_string":"1Genentech Research and Early Development, Genentech Inc., South San Francisco, California","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064058939","display_name":"Christoph Spiess","orcid":"https://orcid.org/0000-0002-0570-9700","observed_orcids":["https://orcid.org/0000-0002-0570-9700"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christoph Spiess","raw_affiliation_strings":["1Genentech Research and Early Development, Genentech Inc., South San Francisco, California"],"raw_orcid":"https://orcid.org/0000-0002-0570-9700","affiliations":[{"raw_affiliation_string":"1Genentech Research and Early Development, Genentech Inc., South San Francisco, California","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012042690","display_name":"Shang\u2010Fan Yu","orcid":"https://orcid.org/0009-0002-2625-663X","observed_orcids":["https://orcid.org/0009-0002-2625-663X"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shang-Fan Yu","raw_affiliation_strings":["1Genentech Research and Early Development, Genentech Inc., South San Francisco, California"],"raw_orcid":"https://orcid.org/0009-0002-2625-663X","affiliations":[{"raw_affiliation_string":"1Genentech Research and Early Development, Genentech Inc., South San Francisco, California","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5022150086","display_name":"Andrew G. Polson","orcid":"https://orcid.org/0000-0003-3289-6502","observed_orcids":["https://orcid.org/0000-0003-3289-6502"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew G. Polson","raw_affiliation_strings":["1Genentech Research and Early Development, Genentech Inc., South San Francisco, California"],"raw_orcid":"https://orcid.org/0000-0003-3289-6502","affiliations":[{"raw_affiliation_string":"1Genentech Research and Early Development, Genentech Inc., South San Francisco, California","institution_ids":["https://openalex.org/I183934855"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.4757,"has_fulltext":false,"cited_by_count":16,"citation_normalized_percentile":{"value":0.80287681,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":95,"max":98},"biblio":{"volume":"12","issue":"1","first_page":"60","last_page":"71"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":0.8481000065803528,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":0.8481000065803528,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.13670000433921814,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0017999999690800905,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mosunetuzumab","display_name":"mosunetuzumab","score":0.9940000176429749},{"id":"https://openalex.org/keywords/nk-cell-activation","display_name":"NK cell activation","score":0.7870000004768372},{"id":"https://openalex.org/keywords/antibody-dependent-cellular-cytotoxicity","display_name":"antibody-dependent cellular cytotoxicity","score":0.9620000123977661},{"id":"https://openalex.org/keywords/antibody-dependent-cellular-phagocytosis","display_name":"antibody-dependent cellular phagocytosis","score":0.9940000176429749},{"id":"https://openalex.org/keywords/macrophages","display_name":"macrophages","score":0.9390000104904175},{"id":"https://openalex.org/keywords/innate-immune-activation","display_name":"innate immune activation","score":0.7879999876022339},{"id":"https://openalex.org/keywords/interleukin-2","display_name":"interleukin-2","score":0.781000018119812},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.8169999718666077},{"id":"https://openalex.org/keywords/il-10","display_name":"IL-10","score":0.8579999804496765},{"id":"https://openalex.org/keywords/tnf-alpha","display_name":"TNF-\u03b1","score":0.9940000176429749},{"id":"https://openalex.org/keywords/cytokine-production","display_name":"cytokine production","score":0.6740000247955322},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.515999972820282},{"id":"https://openalex.org/keywords/hematologic-disorders","display_name":"hematologic disorders","score":0.593999981880188},{"id":"https://openalex.org/keywords/combination-antibody-therapy","display_name":"antibody combination therapy","score":0.5569999814033508}],"concepts":[{"id":"https://openalex.org/C40677261","wikidata":"https://www.wikidata.org/wiki/Q21418091","display_name":"Antibody-dependent cell-mediated cytotoxicity","level":4,"score":0.8975505828857422},{"id":"https://openalex.org/C136449434","wikidata":"https://www.wikidata.org/wiki/Q428253","display_name":"Innate immune system","level":3,"score":0.6836480498313904},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.6285920143127441},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5838019847869873},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5773662328720093},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4972067177295685},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.46977847814559937},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.4389650821685791},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.41538071632385254},{"id":"https://openalex.org/C193419808","wikidata":"https://www.wikidata.org/wiki/Q1645075","display_name":"Acquired immune system","level":3,"score":0.4121280610561371},{"id":"https://openalex.org/C47742525","wikidata":"https://www.wikidata.org/wiki/Q13418826","display_name":"Innate lymphoid cell","level":4,"score":0.41178983449935913},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3474973440170288},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.22077593207359314}],"mesh":[{"descriptor_ui":"D000920","descriptor_name":"Antibody-Dependent Cell Cytotoxicity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007113","descriptor_name":"Immunity, Innate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016207","descriptor_name":"Cytokines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D018033","descriptor_name":"Antibodies, Bispecific","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018033","descriptor_name":"Antibodies, Bispecific","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1158/2326-6066.cir-23-0072","doi":"https://doi.org/10.1158/2326-6066.cir-23-0072","is_oa":false,"landing_page_url":"https://doi.org/10.1158/2326-6066.cir-23-0072","pdf_url":null,"source":{"id":"https://openalex.org/S2765010658","display_name":"Cancer Immunology Research","issn_l":"2326-6066","issn":["2326-6066","2326-6074"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Immunology Research","raw_type":"journal-article"},{"id":"pmid:37902604","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37902604","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer immunology research","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9789000153541565}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320332193","display_name":"Genentech","ror":"https://ror.org/04gndp242"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":35,"referenced_works":["https://openalex.org/W1967512987","https://openalex.org/W1973372748","https://openalex.org/W1979343444","https://openalex.org/W1985579610","https://openalex.org/W1998189366","https://openalex.org/W2010457001","https://openalex.org/W2025000087","https://openalex.org/W2044757050","https://openalex.org/W2054472394","https://openalex.org/W2083553555","https://openalex.org/W2096441981","https://openalex.org/W2104173785","https://openalex.org/W2105330984","https://openalex.org/W2114104545","https://openalex.org/W2116894955","https://openalex.org/W2119147717","https://openalex.org/W2128402413","https://openalex.org/W2130410032","https://openalex.org/W2146512944","https://openalex.org/W2288929640","https://openalex.org/W2509039973","https://openalex.org/W2883425082","https://openalex.org/W2922052367","https://openalex.org/W2964876228","https://openalex.org/W2971490864","https://openalex.org/W3006392123","https://openalex.org/W3082961992","https://openalex.org/W3097855394","https://openalex.org/W3164930583","https://openalex.org/W3165095412","https://openalex.org/W4205824206","https://openalex.org/W4220905480","https://openalex.org/W4221027310","https://openalex.org/W4282033105","https://openalex.org/W6641218128"],"related_works":["https://openalex.org/W4200502215","https://openalex.org/W6946265277","https://openalex.org/W7124680076","https://openalex.org/W7148684759","https://openalex.org/W3167340070","https://openalex.org/W4415900313","https://openalex.org/W2104173785","https://openalex.org/W1844752223","https://openalex.org/W2027536435"],"abstract_inverted_index":{"T":[0,11],"cell-retargeting":[1],"therapies":[2],"have":[3],"transformed":[4],"the":[5,69,96,154],"therapeutic":[6],"landscape":[7],"for":[8,123,140,145,171],"hematologic":[9],"diseases.":[10],"cell-dependent":[12],"bispecific":[13],"antibodies":[14],"(TDB)":[15],"function":[16,88],"as":[17],"conditional":[18],"agonists":[19],"that":[20,55,80,150,176],"induce":[21],"a":[22],"polyclonal":[23],"T-cell":[24],"response,":[25],"resulting":[26],"in":[27,59,62,68,76,165],"target":[28,164],"cell":[29,66],"destruction":[30],"and":[31,39,78,89,94,118,126,143,182],"cytokine":[32],"release.":[33],"The":[34],"relationship":[35],"between":[36],"this":[37,74],"response":[38],"its":[40],"effects":[41],"on":[42],"surrounding":[43],"innate":[44,183],"immune":[45,184],"populations":[46],"has":[47],"not":[48],"been":[49],"fully":[50],"explored.":[51],"Here":[52],"we":[53,148],"show":[54],"treatment":[56,152],"with":[57,116],"mosunetuzumab":[58],"patients":[60],"results":[61,168],"natural":[63],"killer":[64],"(NK)":[65],"activation":[67],"peripheral":[70],"blood.":[71],"We":[72],"modeled":[73],"phenomenon":[75],"vitro":[77],"found":[79],"TDB-mediated":[81],"killing":[82,158],"activated":[83],"NK":[84,87,141],"cells,":[85],"increasing":[86],"antibody-dependent":[90,102],"cellular":[91,103],"cytotoxicity":[92],"(ADCC),":[93],"enhanced":[95,153],"capability":[97],"of":[98,138,156,179],"macrophages":[99],"to":[100,159],"perform":[101],"phagocytosis":[104],"(ADCP).":[105],"This":[106],"enhancement":[107],"was":[108],"triggered":[109],"by":[110],"cytokines":[111],"released":[112],"through":[113,136],"TDB":[114,151],"treatment,":[115],"IL2":[117],"IFN\u03b3":[119],"being":[120],"major":[121],"drivers":[122],"increased":[124],"ADCC":[125],"ADCP,":[127],"respectively.":[128],"Surprisingly,":[129],"cytolytic":[130],"ability":[131],"could":[132],"be":[133],"further":[134],"augmented":[135],"neutralization":[137],"IL10":[139],"cells":[142],"TNF\u03b1":[144],"macrophages.":[146],"Finally,":[147],"showed":[149],"efficacy":[155],"Fc-driven":[157],"an":[160],"orthogonal":[161],"solid":[162],"tumor":[163],"vivo.":[166],"These":[167],"provide":[169],"rationale":[170],"novel":[172],"antibody":[173],"therapy":[174],"combinations":[175],"take":[177],"advantage":[178],"both":[180],"adaptive":[181],"responses.":[185]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4388014101","counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":3}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2023-11-01T00:00:00"}
